$PTCT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PTC THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PTC THERAPEUTICS, INC.. Get notifications about new insider transactions in PTC THERAPEUTICS, INC. for free.
Page: < prev 1 2 3 4 5 6 7 7 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Dec 26 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 48.32 | 6,000 | 289,932 | 53,035 | 59 K to 53 K (-10.16 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 18.01 | 7,656 | 137,885 | 22,969 | |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 18.01 | 7,656 | 137,885 | 22,969 | |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 11.23 | 5,741 | 64,471 | 6,300 | |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 11.23 | 5,741 | 64,471 | 6,300 | |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 12.64 | 1,000 | 12,640 | 875 | |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 12.64 | 1,000 | 12,640 | 875 | |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 11.23 | 559 | 6,278 | 12,041 | |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 11.23 | 559 | 6,278 | 12,041 | |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 12.64 | 125 | 1,580 | 1,875 | |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 12.64 | 125 | 1,580 | 1,875 | |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 10.85 | 3,900 | 42,315 | 0 | |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | M | 10.85 | 3,900 | 42,315 | 0 | |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 7,656 | 382,800 | 18,676 | 26.3 K to 18.7 K (-29.07 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 7,656 | 382,800 | 18,676 | 26.3 K to 18.7 K (-29.07 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 18.01 | 7,656 | 137,885 | 26,332 | 18.7 K to 26.3 K (+40.99 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 18.01 | 7,656 | 137,885 | 26,332 | 18.7 K to 26.3 K (+40.99 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 5,741 | 287,050 | 18,676 | 24.4 K to 18.7 K (-23.51 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 5,741 | 287,050 | 18,676 | 24.4 K to 18.7 K (-23.51 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 11.23 | 5,741 | 64,471 | 24,417 | 18.7 K to 24.4 K (+30.74 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 11.23 | 5,741 | 64,471 | 24,417 | 18.7 K to 24.4 K (+30.74 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 1,000 | 50,000 | 18,676 | 19.7 K to 18.7 K (-5.08 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 1,000 | 50,000 | 18,676 | 19.7 K to 18.7 K (-5.08 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 12.64 | 1,000 | 12,640 | 19,676 | 18.7 K to 19.7 K (+5.35 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 12.64 | 1,000 | 12,640 | 19,676 | 18.7 K to 19.7 K (+5.35 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 559 | 27,950 | 18,676 | 19.2 K to 18.7 K (-2.91 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 559 | 27,950 | 18,676 | 19.2 K to 18.7 K (-2.91 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 11.23 | 559 | 6,278 | 19,235 | 18.7 K to 19.2 K (+2.99 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 11.23 | 559 | 6,278 | 19,235 | 18.7 K to 19.2 K (+2.99 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 125 | 6,250 | 18,676 | 18.8 K to 18.7 K (-0.66 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 125 | 6,250 | 18,676 | 18.8 K to 18.7 K (-0.66 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 12.64 | 125 | 1,580 | 18,801 | 18.7 K to 18.8 K (+0.67 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 12.64 | 125 | 1,580 | 18,801 | 18.7 K to 18.8 K (+0.67 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 3,900 | 195,000 | 18,676 | 22.6 K to 18.7 K (-17.27 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 3,900 | 195,000 | 18,676 | 22.6 K to 18.7 K (-17.27 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 10.85 | 3,900 | 42,315 | 22,576 | 18.7 K to 22.6 K (+20.88 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Buy | M | 10.85 | 3,900 | 42,315 | 22,576 | 18.7 K to 22.6 K (+20.88 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 3,482 | 174,100 | 18,676 | 22.2 K to 18.7 K (-15.71 %) |
Dec 05 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Sell | S | 50.00 | 3,482 | 174,100 | 18,676 | 22.2 K to 18.7 K (-15.71 %) |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 18.01 | 4,375 | 78,794 | 43,750 | |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 18.01 | 4,375 | 78,794 | 48,125 | |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 11.23 | 3,281 | 36,846 | 19,688 | |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 11.23 | 3,281 | 36,846 | 22,969 | |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.34 | 1,441 | 65,329 | 29,524 | 31 K to 29.5 K (-4.65 %) |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 44.45 | 2,934 | 130,428 | 30,965 | 33.9 K to 31 K (-8.66 %) |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 18.01 | 4,375 | 78,794 | 33,899 | 29.5 K to 33.9 K (+14.82 %) |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.31 | 1,399 | 63,394 | 29,524 | 30.9 K to 29.5 K (-4.52 %) |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 44.46 | 2,976 | 132,313 | 30,923 | 33.9 K to 30.9 K (-8.78 %) |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 18.01 | 4,375 | 78,794 | 33,899 | 29.5 K to 33.9 K (+14.82 %) |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.34 | 1,098 | 49,787 | 29,524 | 30.6 K to 29.5 K (-3.59 %) |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 44.46 | 2,183 | 97,047 | 30,622 | 32.8 K to 30.6 K (-6.65 %) |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 11.23 | 3,281 | 36,846 | 32,805 | 29.5 K to 32.8 K (+11.11 %) |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.34 | 1,000 | 45,342 | 29,524 | 30.5 K to 29.5 K (-3.28 %) |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 44.48 | 2,281 | 101,457 | 30,524 | 32.8 K to 30.5 K (-6.95 %) |
Jul 09 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 11.23 | 3,281 | 36,846 | 32,805 | 29.5 K to 32.8 K (+11.11 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 18.01 | 17,500 | 315,175 | 52,500 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 11.23 | 2,142 | 24,055 | 26,250 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 27.05 | 70,849 | 1,916,465 | 0 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 27.05 | 7,307 | 197,654 | 70,849 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 10.85 | 384 | 4,166 | 0 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 10.85 | 5,910 | 64,124 | 0 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 11.23 | 1,140 | 12,802 | 28,392 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 11.23 | 22,968 | 257,931 | 29,532 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 27.05 | 1,844 | 49,880 | 78,156 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 10.85 | 44,090 | 478,377 | 5,910 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | M | 10.85 | 7,533 | 81,733 | 384 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.00 | 17,500 | 787,500 | 29,524 | 47 K to 29.5 K (-37.22 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 18.01 | 17,500 | 315,175 | 47,024 | 29.5 K to 47 K (+59.27 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.00 | 2,142 | 96,390 | 29,524 | 31.7 K to 29.5 K (-6.76 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 11.23 | 2,142 | 24,055 | 31,666 | 29.5 K to 31.7 K (+7.26 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.00 | 70,849 | 3,188,205 | 29,524 | 100.4 K to 29.5 K (-70.59 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 27.05 | 70,849 | 1,916,465 | 100,373 | 29.5 K to 100.4 K (+239.97 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.00 | 7,307 | 328,815 | 29,524 | 36.8 K to 29.5 K (-19.84 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 27.05 | 7,307 | 197,654 | 36,831 | 29.5 K to 36.8 K (+24.75 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.00 | 384 | 17,280 | 29,524 | 29.9 K to 29.5 K (-1.28 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 10.85 | 384 | 4,166 | 29,908 | 29.5 K to 29.9 K (+1.30 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.00 | 5,910 | 265,950 | 29,524 | 35.4 K to 29.5 K (-16.68 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 10.85 | 5,910 | 64,124 | 35,434 | 29.5 K to 35.4 K (+20.02 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.00 | 1,140 | 51,300 | 29,524 | 30.7 K to 29.5 K (-3.72 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 11.23 | 1,140 | 12,802 | 30,664 | 29.5 K to 30.7 K (+3.86 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.00 | 22,968 | 1,033,560 | 29,524 | 52.5 K to 29.5 K (-43.76 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 11.23 | 22,968 | 257,931 | 52,492 | 29.5 K to 52.5 K (+77.79 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.00 | 1,844 | 82,980 | 29,524 | 31.4 K to 29.5 K (-5.88 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 27.05 | 1,844 | 49,880 | 31,368 | 29.5 K to 31.4 K (+6.25 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.00 | 44,090 | 1,984,050 | 29,524 | 73.6 K to 29.5 K (-59.89 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 10.85 | 44,090 | 478,377 | 73,614 | 29.5 K to 73.6 K (+149.34 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Sell | S | 45.00 | 7,533 | 338,985 | 29,524 | 37.1 K to 29.5 K (-20.33 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Buy | M | 10.85 | 7,533 | 81,733 | 37,057 | 29.5 K to 37.1 K (+25.51 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 18.01 | 9,297 | 167,439 | 30,000 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 30.86 | 641 | 19,781 | 10,310 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 27.05 | 3,133 | 84,748 | 0 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 18.01 | 703 | 12,661 | 39,297 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 30.86 | 49 | 1,512 | 10,951 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Option Exercise | M | 27.05 | 236 | 6,384 | 3,133 | |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 45.15 | 9,297 | 419,750 | 4,937 | 14.2 K to 4.9 K (-65.32 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 18.01 | 9,297 | 167,439 | 14,234 | 4.9 K to 14.2 K (+188.31 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 45.15 | 641 | 28,941 | 4,937 | 5.6 K to 4.9 K (-11.49 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 30.86 | 641 | 19,781 | 5,578 | 4.9 K to 5.6 K (+12.98 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 45.15 | 3,133 | 141,452 | 4,937 | 8.1 K to 4.9 K (-38.82 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 27.05 | 3,133 | 84,748 | 8,070 | 4.9 K to 8.1 K (+63.46 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 45.00 | 703 | 31,635 | 4,937 | 5.6 K to 4.9 K (-12.46 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 18.01 | 703 | 12,661 | 5,640 | 4.9 K to 5.6 K (+14.24 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 45.00 | 49 | 2,205 | 4,937 | 5 K to 4.9 K (-0.98 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 30.86 | 49 | 1,512 | 4,986 | 4.9 K to 5 K (+0.99 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Sell | S | 45.00 | 236 | 10,620 | 4,937 | 5.2 K to 4.9 K (-4.56 %) |
Jul 02 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | SVP, Finance & CAO | Buy | M | 27.05 | 236 | 6,384 | 5,173 | 4.9 K to 5.2 K (+4.78 %) |
Jun 04 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Sell | S | 40.38 | 5,490 | 221,686 | 58,664 | 64.2 K to 58.7 K (-8.56 %) |
Jun 03 2019 | PTCT | PTC THERAPEUTICS, ... | Hill Emily Luisa | Chief Financial Off ... | Option Exercise | A | 40.10 | 50,000 | 2,005,000 | 50,000 | |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Option Exercise | M | 11.23 | 6,300 | 70,749 | 6,300 | |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Option Exercise | M | 13.10 | 18,750 | 245,625 | 6,250 | |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Option Exercise | M | 10.85 | 1,150 | 12,478 | 0 | |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Sell | S | 35.17 | 3,540 | 124,502 | 4,937 | 8.5 K to 4.9 K (-41.76 %) |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Sell | S | 34.70 | 2,760 | 95,772 | 8,477 | 11.2 K to 8.5 K (-24.56 %) |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Buy | M | 11.23 | 6,300 | 70,749 | 11,237 | 4.9 K to 11.2 K (+127.61 %) |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Sell | S | 35.21 | 8,821 | 310,587 | 4,937 | 13.8 K to 4.9 K (-64.12 %) |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Sell | S | 34.75 | 9,929 | 345,033 | 13,758 | 23.7 K to 13.8 K (-41.92 %) |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Buy | M | 13.10 | 18,750 | 245,625 | 23,687 | 4.9 K to 23.7 K (+379.79 %) |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Sell | S | 35.17 | 610 | 21,454 | 4,937 | 5.5 K to 4.9 K (-11.00 %) |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Sell | S | 34.71 | 540 | 18,743 | 5,547 | 6.1 K to 5.5 K (-8.87 %) |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Buy | M | 10.85 | 1,150 | 12,478 | 6,087 | 4.9 K to 6.1 K (+23.29 %) |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Sell | S | 35.25 | 1,000 | 35,250 | 4,937 | 5.9 K to 4.9 K (-16.84 %) |
Mar 07 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Sell | S | 34.78 | 1,509 | 52,483 | 5,937 | 7.4 K to 5.9 K (-20.27 %) |
Jan 29 2019 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Buy | P | 30.20 | 66,225 | 1,999,995 | 1,386,594 | 1.3 M to 1.4 M (+5.02 %) |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Option Exercise | A | 33.02 | 10,100 | 333,502 | 10,100 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Utter Christine Marie | Principal Financial ... | Option Exercise | A | 33.02 | 42,500 | 1,403,350 | 42,500 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | A | 33.02 | 17,500 | 577,850 | 17,500 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Boulding Mark Elliott | Exec. VP and CLO | Option Exercise | A | 33.02 | 72,500 | 2,393,950 | 72,500 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | SCHMERTZLER MICHAEL | Director | Option Exercise | A | 33.02 | 28,000 | 924,560 | 28,000 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | STEELE GLENN JR MD PHD | Director | Option Exercise | A | 33.02 | 14,000 | 462,280 | 14,000 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Svoronos Dawn | Director | Option Exercise | A | 33.02 | 14,000 | 462,280 | 14,000 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Okey Stephanie | Director | Option Exercise | A | 33.02 | 14,000 | 462,280 | 14,000 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | ZELDIS JEROME B | Director | Option Exercise | A | 33.02 | 14,000 | 462,280 | 14,000 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Reeve Emma | Director | Option Exercise | A | 33.02 | 14,000 | 462,280 | 14,000 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | SOUTHWELL DAVID P | Director | Option Exercise | A | 33.02 | 14,000 | 462,280 | 14,000 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Jacobson Allan Steven | Director | Option Exercise | A | 33.02 | 14,000 | 462,280 | 14,000 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | A | 33.02 | 26,950 | 889,889 | 26,950 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | A | 33.02 | 55,000 | 1,816,100 | 55,000 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Option Exercise | A | 33.02 | 265,000 | 8,750,300 | 265,000 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Peltz Stuart Walter | Chief Executive Off ... | Grant | A | 0.00 | 4,620 | 0 | 22,158 | 17.5 K to 22.2 K (+26.34 %) |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | A | 33.02 | 17,500 | 577,850 | 17,500 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Option Exercise | A | 33.02 | 72,500 | 2,393,950 | 72,500 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Grant | A | 0.00 | 570 | 0 | 6,219 | 5.6 K to 6.2 K (+10.09 %) |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Option Exercise | A | 33.02 | 6,825 | 225,362 | 6,825 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Option Exercise | A | 33.02 | 25,000 | 825,500 | 25,000 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Option Exercise | A | 33.02 | 112,500 | 3,714,750 | 112,500 | |
Jan 24 2019 | PTCT | PTC THERAPEUTICS, ... | Souza Marcio | Chief Operating Off ... | Grant | A | 0.00 | 1,925 | 0 | 4,667 | 2.7 K to 4.7 K (+70.20 %) |
Jan 09 2019 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 34.75 | 68 | 2,363 | 5,649 | 5.7 K to 5.6 K (-1.19 %) |
Jan 09 2019 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 34.75 | 55 | 1,911 | 5,717 | 5.8 K to 5.7 K (-0.95 %) |
Jan 09 2019 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 34.75 | 57 | 1,981 | 5,772 | 5.8 K to 5.8 K (-0.98 %) |
Jan 09 2019 | PTCT | PTC THERAPEUTICS, ... | Almstead Neil Gregory | Chief Technical Ops ... | Sell | S | 34.75 | 473 | 16,437 | 17,396 | 17.9 K to 17.4 K (-2.65 %) |